서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 5 of 5

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2018-07	Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial Tripathy, Debu; Im, Seock-Ah; Colleoni, Marco; Franke, Fabio; Bardia, Aditya; Harbeck, Nadia; Hurvitz, Sara A.; Chow, Louis; Sohn, Joohyuk; Lee, Keun Seok; Campos-Gomez, Saul; Vazquez, Rafael Villanueva; Jung, Kyung Hae; Babu, K. Govind; Wheatley-Price, Paul; De laurentiis, Michelino; Im, Young-Hyuck; Kuemmel, Sherko; El-Saghir, Nagi; Liu, Mei-Ching; Carlson, Gary; Hughes, Gareth; Diaz-Padilla, Ivan; Germa, Caroline; Hirawat, Samit; Lu, Yen-Shen The Lancet Oncology, Vol.19 No.7, pp.904-915	DOI
2021-11	EFFECTS OF PEMBROLIZUMAB ON THE TUMOR MICROENVIRONMENT (TME) AFTER ONE PRESURGERY TREATMENT CYCLE IN PATIENTS WITH TRIPLE-NEGATIVE BREAST CANCER (TNBC): PHASE 1B KEYNOTE-173 STUDY Schmid, Peter; Park, Yeon Hee; Munoz-Couselo, Eva; Kim, Sung-Bae; Sohn, Joohyuk; Im, Seock-Ah; Holgado, Esther; Foukakis, Theodoros; Kuemmel, Sherko; Dent, Rebecca; Sun, Yuan; Huang, Lingkang; Yearley, Jennifer; Jelinic, Petar; Karantza, Vassiliki; Cortes, Javier Journal for ImmunoTherapy of Cancer, Vol.9, pp.A364-A364	DOI
2022-01	A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer Kuemmel, Sherko; Campone, Mario; Loirat, Delphine; Lopez Lopez, Rafael; Beck, J. Thaddeus; De Laurentiis, Michelino; Im, Seock-Ah; Kim, Sung-Bae; Kwong, Ava; Steger, Guenther G.; Adelantado, Esther Zamora; Duhoux, Francois P.; Greil, Richard; Kuter, Irene; Lu, Yen-Shen; Tibau, Ariadna; Ozguroglu, Mustafa; Scholz, Christian W.; Singer, Christian F.; Vega, Estela; Wimberger, Pauline; Zamagni, Claudio; Couillebault, Xuan-Mai; Fan, Liqiong; Guerreiro, Nelson; Mataraza, Jennifer; Sand-Dejmek, Janna; Chan, Arlene Clinical Cancer Research, Vol.28 No.1, pp.106-115	DOI
2022-03	Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2(-) Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial Lu, Yen-Shen; Im, Seock-Ah; Colleoni, Marco; Franke, Fabio; Bardia, Aditya; Cardoso, Fatima; Harbeck, Nadia; Hurvitz, Sara; Chow, Louis; Sohn, Joohyuk; Lee, Keun Seok; Campos-Gomez, Saul; Vazquez, Rafael Villanueva; Jung, Kyung Hae; Babu, K. Govind; Wheatley-Price, Paul; De Laurentiis, Michelino; Im, Young-Hyuck; Kuemmel, Sherko; El-Saghir, Nagi; O'Regan, Ruth; Gasch, Claudia; Solovieff, Nadia; Wang, Craig; Wang, Yongyu; Chakravartty, Arunava; Ji, Yan; Tripathy, Debu Clinical Cancer Research, Vol.28 No.5, pp.851-859	DOI
2024-04	Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer Ganz, Patricia A.; Bandos, Hanna; Španić, Tanja; Friedman, Sue; Müller, Volkmar; Kuemmel, Sherko; Delaloge, Suzette; Brain, Etienne; Toi, Masakazu; Yamauchi, Hideko; De Dueñas, Eduardo-M.; Armstrong, Anne; Im, Seock Ah; Song, Chuan-Gui; Zheng, Hong; Sarosiek, Tomasz; Sharma, Priyanka; Geng, Cuizhi; Fu, Peifen; Rhiem, Kerstin; Frauchiger-Heuer, Heike; Wimberger, Pauline; T'Kint De Roodenbeke, Daphné; Liao, Ning; Goodwin, Annabel; Chakiba-Brugère, Camille; Friedlander, Michael; Lee, Keun Seok; Giacchetti, Sylvie; Takano, Toshimi; Henao-Carrasco, Fernando; Virani, Shamsuddin; Valdes-Albini, Frances; Domchek, Susan M.; Bane, Charles; McCarron, Edward C.; Mita, Monica; Rossi, Giovanna; Rastogi, Priya; Fielding, Anitra; Gelber, Richard D.; Scheepers, Elsemieke D.; Cameron, David; Garber, Judy; Geyer, Charles E.; Tutt, Andrew N.J. Journal of Clinical Oncology, Vol.42 No.11, pp.1288-1300	DOI

1